Literature DB >> 23650021

Factors influencing the effectiveness of scalp cooling in the prevention of chemotherapy-induced alopecia.

Manon M C Komen1, Carolien H Smorenburg, Corina J G van den Hurk, Johan W R Nortier.   

Abstract

The success of scalp cooling in preventing or reducing chemotherapy-induced alopecia (CIA) is highly variable between patients and chemotherapy regimens. The outcome of hair preservation is often unpredictable and depends on various factors. Methods. We performed a structured search of literature published from 1970 to February 2012 for articles that reported on factors influencing the effectiveness of scalp cooling to prevent CIA in patients with cancer. Results. The literature search identified 192 reports, of which 32 studies were considered relevant. Randomized studies on scalp cooling are scarce and there is little information on the determinants of the result. The effectiveness of scalp cooling for hair preservation depends on dose and type of chemotherapy, with less favorable results at higher doses. Temperature seems to be an important determinant. Various studies suggest that a subcutaneous scalp temperature less than 22 °C is required for hair preservation. Conclusions. The effectiveness of scalp cooling for hair preservation varies by chemotherapy type and dose, and probably by the degree and duration of cooling.

Entities:  

Keywords:  Alopecia; Chemotherapy; Scalp cooling; Side effects

Mesh:

Year:  2013        PMID: 23650021      PMCID: PMC3720643          DOI: 10.1634/theoncologist.2012-0332

Source DB:  PubMed          Journal:  Oncologist        ISSN: 1083-7159


  40 in total

1.  Efficacy of penguin cap as scalp cooling system for prevention of alopecia in patients undergoing chemotherapy.

Authors:  Marzieh Kargar; Raheleh Sabet Sarvestani; Habib Noorani Khojasteh; Mohammad Taghi Heidari
Journal:  J Adv Nurs       Date:  2011-06-02       Impact factor: 3.187

2.  Evaluating the efficacy of scalp cooling using the Penguin cold cap system to reduce alopecia in patients undergoing chemotherapy for breast cancer.

Authors:  H J Peck; H Mitchell; A L Stewart
Journal:  Eur J Oncol Nurs       Date:  2000-12       Impact factor: 2.398

3.  Modelling of temperature and perfusion during scalp cooling.

Authors:  F E M Janssen; G M J Van Leeuwen; A A Van Steenhoven
Journal:  Phys Med Biol       Date:  2005-08-17       Impact factor: 3.609

4.  Effectiveness of scalp cooling in reducing alopecia caused by epirubicin treatment of advanced breast cancer.

Authors:  M H Robinson; A C Jones; K D Durrant
Journal:  Cancer Treat Rep       Date:  1987-10

5.  Scalp hypothermia in the prevention of doxorubicin-induced hair loss.

Authors:  G Giaccone; F Di Giulio; M P Morandini; A Calciati
Journal:  Cancer Nurs       Date:  1988-06       Impact factor: 2.592

6.  Scalp hypothermia to prevent adriamycin-induced hair loss.

Authors:  J M Hunt; J E Anderson; I E Smith
Journal:  Cancer Nurs       Date:  1982-02       Impact factor: 2.592

7.  Scalp cooling to prevent chemotherapy-induced hair loss: practical and clinical considerations.

Authors:  Floortje Mols; Corina J van den Hurk; Ad J J M Vingerhoets; Wim P M Breed
Journal:  Support Care Cancer       Date:  2008-06-17       Impact factor: 3.603

8.  The effectiveness of scalp cooling in preventing alopecia for patients receiving epirubicin and docetaxel.

Authors:  C Macduff; T Mackenzie; A Hutcheon; L Melville; H Archibald
Journal:  Eur J Cancer Care (Engl)       Date:  2003-06       Impact factor: 2.520

9.  Ineffectiveness of scalp hypothermia in the prevention of alopecia in patients treated with doxorubicin and cisplatin combinations.

Authors:  J B Wheelock; M B Myers; H B Krebs; D R Goplerud
Journal:  Cancer Treat Rep       Date:  1984-11

Review 10.  Scalp cooling has no place in the prevention of alopecia in adjuvant chemotherapy for breast cancer.

Authors:  R A Tollenaar; G J Liefers; O J Repelaer van Driel; C J van de Velde
Journal:  Eur J Cancer       Date:  1994       Impact factor: 9.162

View more
  24 in total

1.  Association Between Use of a Scalp Cooling Device and Alopecia After Chemotherapy for Breast Cancer.

Authors:  Hope S Rugo; Paula Klein; Susan Anitra Melin; Sara A Hurvitz; Michelle E Melisko; Anne Moore; Glen Park; Jules Mitchel; Erika Bågeman; Ralph B D'Agostino; Elizabeth S Ver Hoeve; Laura Esserman; Tessa Cigler
Journal:  JAMA       Date:  2017-02-14       Impact factor: 56.272

2.  Hair regrowth using a properly fitted scalp cooling cap during adjuvant chemotherapy for breast cancer.

Authors:  Atsushi Fushimi; Noboru Shinozaki; Hiroshi Takeyama
Journal:  Int Cancer Conf J       Date:  2019-06-17

Review 3.  A Clinical and Biological Guide for Understanding Chemotherapy-Induced Alopecia and Its Prevention.

Authors:  Christopher John Dunnill; Wafaa Al-Tameemi; Andrew Collett; Iain Stuart Haslam; Nikolaos Theodoros Georgopoulos
Journal:  Oncologist       Date:  2017-09-26

4.  Chemotherapy drug concentrations in hair follicles: a potential biomarker to monitor the effectiveness of scalp cooling for chemotherapy-induced alopecia.

Authors:  Jung-Woo Chae; Raymond Ng; Alexandre Chan
Journal:  Support Care Cancer       Date:  2018-06-26       Impact factor: 3.603

5.  Prolonging the duration of post-infusion scalp cooling in the prevention of anthracycline-induced alopecia: a randomised trial in patients with breast cancer treated with adjuvant chemotherapy.

Authors:  Manon M C Komen; Corina J G van den Hurk; Johan W R Nortier; Tjeerd van der Ploeg; P Nieboer; Jacobus J M van der Hoeven; Carolien H Smorenburg
Journal:  Support Care Cancer       Date:  2018-09-11       Impact factor: 3.603

Review 6.  Dermatological adverse events with taxane chemotherapy.

Authors:  Vincent Sibaud; Nicole R Lebœuf; Henri Roche; Viswanath R Belum; Laurence Gladieff; Marion Deslandres; Marion Montastruc; Audrey Eche; Emmanuelle Vigarios; Florence Dalenc; Mario E Lacouture
Journal:  Eur J Dermatol       Date:  2016-10-01       Impact factor: 3.328

7.  Considerations for the Use of Scalp Cooling Devices in Black Patients.

Authors:  Erinolaoluwa F Araoye; Vered Stearns; Crystal Aguh
Journal:  J Clin Oncol       Date:  2020-09-08       Impact factor: 44.544

8.  Parathyroid hormone linked to a collagen binding domain promotes hair growth in a mouse model of chemotherapy-induced alopecia in a dose-dependent manner.

Authors:  Ranjitha Katikaneni; Tulasi Ponnapakkam; Andrew Seymour; Joshua Sakon; Robert Gensure
Journal:  Anticancer Drugs       Date:  2014-08       Impact factor: 2.248

9.  Cryotherapy for docetaxel-induced hand and nail toxicity: randomised control trial.

Authors:  Alexandra L McCarthy; Ramon Z Shaban; Kerri Gillespie; Joanne Vick
Journal:  Support Care Cancer       Date:  2013-12-22       Impact factor: 3.603

10.  Results of 20- versus 45-min post-infusion scalp cooling time in the prevention of docetaxel-induced alopecia.

Authors:  Manon M C Komen; Wim P M Breed; Carolien H Smorenburg; Tjeerd van der Ploeg; S H Goey; Jacobus J M van der Hoeven; Johan W R Nortier; Corina J G van den Hurk
Journal:  Support Care Cancer       Date:  2016-01-25       Impact factor: 3.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.